Business Description
Central Asia Lumeichun Biotechnology Inc
NAICS : 112390
SIC : 7999
ISIN : US8888471005
Description
Central Asia Lumeichun Biotechnology Inc. is a China-based ecological agriculture company. Its operations center on a sika deer breeding base in southern China, where it raises sika deer for velvet antler and related animal-derived products used in traditional Chinese medicine and health supplements. The company also engages in ecological agricultural cultivation, integrating deer husbandry with crop and forage production. Its customers are primarily Chinese pharmaceutical, health food, and traditional medicine manufacturers and distributors, with sales concentrated in the domestic Chinese market. Revenue is generated through the sale of deer products, including antler and other byproducts, as well as agricultural goods, rather than through service fees or licensing. The business is small in scale and focused on vertically integrated breeding and cultivation within its regional base.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 6.82 | |||||
9-Day RSI | 19.97 | |||||
14-Day RSI | 26.84 | |||||
3-1 Month Momentum % | -62.89 | |||||
6-1 Month Momentum % | -68.09 | |||||
12-1 Month Momentum % | -68.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ZYLM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Central Asia Lumeichun Biotechnology Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.361 | ||
| EPS (TTM) ($) | 0.335 | ||
| Beta | -2.4237 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.61 | ||
| Volatility % | 97.21 | ||
| 14-Day RSI | 26.84 | ||
| 14-Day ATR ($) | 0.050059 | ||
| 20-Day SMA ($) | 0.35386 | ||
| 12-1 Month Momentum % | -68.09 | ||
| 52-Week Range ($) | 0.1636 - 6.35 | ||
| Shares Outstanding (Mil) | 0.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Central Asia Lumeichun Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Central Asia Lumeichun Biotechnology Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.002:1 Stock Split | 2026-07-28 | 0.45 (-47.06%) | ||
| 0.002:1 Stock Split | 2015-01-12 | 5,500.00 (+0.00%) | ||
| 0.01:1 Stock Split | 2013-03-06 | 150,000.00 (-25.00%) | ||
| 0.05:1 Stock Split | 2005-01-18 | -- |
Show
Entries
Central Asia Lumeichun Biotechnology Inc Frequently Asked Questions
What is Central Asia Lumeichun Biotechnology Inc(ZYLM)'s stock price today?
The current price of ZYLM is $0.16. The 52 week high of ZYLM is $6.35 and 52 week low is $0.16.
When is next earnings date of Central Asia Lumeichun Biotechnology Inc(ZYLM)?
The next earnings date of Central Asia Lumeichun Biotechnology Inc(ZYLM) is .
Does Central Asia Lumeichun Biotechnology Inc(ZYLM) pay dividends? If so, how much?
Central Asia Lumeichun Biotechnology Inc(ZYLM) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers